FINHUB Insights

STE · Q2 FY26 · Jul 1 – Sep 30, 2025

Steris Q2 FY26: where the revenue came from and where it went

Steris Q2 FY26: revenue $1.5B (+10% year over year). Net profit $0.2B. Largest cohort Healthcare $1B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Nov 6, 2025 10-Q
Sankey diagram of Steris's income statement for Q2 FY26: revenue of $1.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.5B +10% year over year
Gross profit$0.6B 44% margin
Operating profit$0.3B 18% margin
Net profit$0.2B 13% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 1.5 100% +10%
Healthcare 1 67% +9%
Applied Sterilization Technologies 0.3 20% +10%
Life Science 0.1 7% +13%
Cost of revenue−0.853%
Gross profit0.644% margin+1pp
Research & development−02%+0pp
SG&A−0.424%−1pp
Operating profit0.318% margin+2pp
Tax−0.1
Net profit0.213%+2pp
Filing on EDGAR More quarters of STE

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters